标题
Antiresorptive therapies for osteoporosis: a clinical overview
作者
关键词
-
出版物
Nature Reviews Endocrinology
Volume 8, Issue 2, Pages 81-91
出版商
Springer Nature
发表日期
2011-09-06
DOI
10.1038/nrendo.2011.146
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bisphosphonate-associated adverse events
- (2014) Peter Papapetrou Hormones-International Journal of Endocrinology and Metabolism
- Bisphosphonate Use and the Risk of Adverse Jaw Outcomes
- (2014) Vassiliki M. Cartsos et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
- (2011) Jacqueline R. Center et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and meta-analysis
- (2010) Rohit Bhuriya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
- (2010) Chris R. Cardwell et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perspectives: How many women have osteoporosis now?
- (2010) Joseph L. Melton JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Low-trauma fractures indicate increased risk of hip fracture in frail older people
- (2010) Jian Sheng Chen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
- (2010) Mark J. Bolland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
- (2010) P. N. Sambrook et al. OSTEOPOROSIS INTERNATIONAL
- New Selective Estrogen Receptor Modulators (SERMs) in Development
- (2010) Stuart L. Silverman Current Osteoporosis Reports
- Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
- (2009) R. K. Dore et al. ANNALS OF THE RHEUMATIC DISEASES
- Secondary osteoporosis in patients with an osteoporotic fracture
- (2009) C. Kok et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
- (2009) Anselm Mak et al. BMC MUSCULOSKELETAL DISORDERS
- Prevention of osteoporosis-related fractures among postmenopausal women and older men
- (2009) P. Rahmani et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Comparative Effects of Teriparatide and Strontium Ranelate on Bone Biopsies and Biochemical Markers of Bone Turnover in Postmenopausal Women With Osteoporosis*
- (2009) Robert R Recker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture
- (2009) Cathleen S Colón-Emeric et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Estrogen and progestogen use in postmenopausal women
- (2009) &NA; MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
- (2008) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study
- (2008) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Revised Clinician’s Guide to the Prevention and Treatment of Osteoporosis
- (2008) Bess Dawson-Hughes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate
- (2008) Brett A. Lenart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of osteoporosis in primary care in Australia
- (2008) J. S. Chen et al. OSTEOPOROSIS INTERNATIONAL
- Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data
- (2008) A. Cranney et al. OSTEOPOROSIS INTERNATIONAL
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
- FRAX™ and the assessment of fracture probability in men and women from the UK
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More